These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6927125)

  • 21. [Determination of erythromycin concentration in body fluids after intravenous application].
    PILLER M; BERNSTEIN A
    Schweiz Med Wochenschr; 1955 Jan; 85(5):104-8. PubMed ID: 14358614
    [No Abstract]   [Full Text] [Related]  

  • 22. Measured copper and zinc in body fluids.
    Klevay LM
    J Trace Elem Med Biol; 1998 Mar; 12(1):1. PubMed ID: 9638605
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of furosemide on extravascular diffusion, protein binding and urinary excretion of cephalosporins and aminoglycosides in rabbits.
    Carbon C; Contrepois A; Vigneron AM; Lamotte-Barrillon S
    J Pharmacol Exp Ther; 1980 Jun; 213(3):600-6. PubMed ID: 7205620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic characteristics of the new veterinary antibiotic turimycin.
    Hoffmann H; Härtl A
    Pol J Pharmacol Pharm; 1980; 32(2):211-6. PubMed ID: 7454625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
    Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnamycin. III. Preliminary studies on absorption and excretion after single dosage.
    ENGLISH AR; FIELD MF; REILLY J; MCNIERNEY J; P'AN SY
    Antibiot Chemother (Northfield); 1953 Mar; 3(3):307-13. PubMed ID: 24542388
    [No Abstract]   [Full Text] [Related]  

  • 27. Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.
    Ambrose KD; Nisbet R; Stephens DS
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4203-9. PubMed ID: 16189099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae.
    Lonks JR; Garau J; Gomez L; Xercavins M; Ochoa de Echagüen A; Gareen IF; Reiss PT; Medeiros AA
    Clin Infect Dis; 2002 Sep; 35(5):556-64. PubMed ID: 12173129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrolide-resistant Campylobacter: the meat of the matter.
    Belanger AE; Shryock TR
    J Antimicrob Chemother; 2007 Oct; 60(4):715-23. PubMed ID: 17704515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance to macrolides in the species Streptococcus pyogenes in the Czech Republic in 1996-2003].
    Urbásková P; Jakubů V;
    Epidemiol Mikrobiol Imunol; 2004 Nov; 53(4):196-202. PubMed ID: 15633541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reference ranges for analytes in extravascular body fluids.
    Heil W; Edelmann J; Kiemstedt W; Zawta B
    Clin Lab; 2001; 47(1-2):7-16. PubMed ID: 11214226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolation and structure of the main metabolite of macrolide antibiotic turimycin H (author's transl)].
    Fricke H; Schade W; Härtl A; Drewello S
    Pharmazie; 1981 Nov; 36(11):763-7. PubMed ID: 7323124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uranium(VI) solubility and speciation in simulated elemental human biological fluids.
    Sutton M; Burastero SR
    Chem Res Toxicol; 2004 Nov; 17(11):1468-80. PubMed ID: 15540945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
    Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New developments in the field of antibiotics. II].
    BRUNNER R
    Med Welt; 1963 Jul; 30():1517-21 contd. PubMed ID: 14016329
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of biological fluids on the release of 125I from povidone-iodine.
    Abdullah ME; Said SA; Al-Shora H
    Arzneimittelforschung; 1981; 31(5):828-30. PubMed ID: 7196745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evoked effects of cholesterol binding on biomembrane integral proteins; new aspects of cholesterol distribution in human body fluids.
    Alivisatos SG; Deliconstantinos G
    Prog Clin Biol Res; 1982; 102 Pt B():479-89. PubMed ID: 7163182
    [No Abstract]   [Full Text] [Related]  

  • 40. Keratan sulfate in body fluids in joint disease.
    Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
    Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.